NHLBI TOPMed: Early-Onset Atrial Fibrillation in the Estonian Biobank
Demographics (2)
- sex - Gender of participant (phv00430043.v1.p1)
- SEX - Biological Sex (phv00534494.v1.p1)
Race and Ethnicity (1)
- race - Race of participant (phv00430044.v1.p1)
Other (15)
- af_status - AF status (phv00430042.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00430047.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00430046.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00430037.v1.p1)
- Funding_Source - Project funding source (phv00430050.v1.p1)
- IS_TUMOR - Tumor status (phv00430048.v1.p1)
- SAMPLE_ID - Sample ID (phv00430045.v1.p1)
- SAMPLE_ID - Sample ID (phv00430040.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00430049.v1.p1)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00430053.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00430041.v1.p1)
- SUBJECT_ID - Subject ID (phv00430036.v1.p1)
- SUBJECT_ID - Subject ID (phv00430039.v1.p1)
- TOPMed_Phase - TOPMed Phase (phv00430051.v1.p1)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00430052.v1.p1)